Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eszter Molnar

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 12, 2011
[Etiopathology and therapy of seasonal affective disorder]Eszter Molnar, Xenia Gonda, Zoltan Rihmer, et al.
Behavioural Brain Research|August 12, 2009
Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep reboundTamas Kitka, Zita Katai, Dorottya Pap, et al.
Biological Psychiatry|May 20, 2008
New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotypeJudit Lazary, Aron Lazary, Xenia Gonda, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 7, 2010
Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatmentNorbert Gyongyosi, Brigitta Balogh, Zita Katai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectraSandor Kantor, Rita Jakus, Eszter Molnar, et al.
The International Journal of Neuropsychopharmacology|February 12, 2008
Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 daysEszter Kirilly, Eszter Molnar, Brigitta Balogh, et al.
Analytical Biochemistry|June 2, 2009
Detection of protein complex interactions via a Blue Native-PAGE retardation assayMahima Swamy, Eszter Molnar, Thomas Bock, et al.
Advances in Experimental Medicine and Biology|December 11, 2008
Segregation modelsElaine P Dopfer, Mahima Swamy, Gabrielle M Siegers, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 3, 2009
Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotypeJudit Lazary, Aron Lazary, Xenia Gonda, et al.
Neurochemistry International|July 12, 2011
Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivationTamas Kitka, Csaba Adori, Zita Katai, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology|January 12, 2011
[Etiopathology and therapy of seasonal affective disorder]Eszter Molnar, Xenia Gonda, Zoltan Rihmer, et al.
Behavioural Brain Research|August 12, 2009
Small platform sleep deprivation selectively increases the average duration of rapid eye movement sleep episodes during sleep reboundTamas Kitka, Zita Katai, Dorottya Pap, et al.
Biological Psychiatry|May 20, 2008
New evidence for the association of the serotonin transporter gene (SLC6A4) haplotypes, threatening life events, and depressive phenotypeJudit Lazary, Aron Lazary, Xenia Gonda, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 7, 2010
Activation of 5-HT3 receptors leads to altered responses 6 months after MDMA treatmentNorbert Gyongyosi, Brigitta Balogh, Zita Katai, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 9, 2005
Despite similar anxiolytic potential, the 5-hydroxytryptamine 2C receptor antagonist SB-242084 [6-chloro-5-methyl-1-[2-(2-methylpyrid-3-yloxy)-pyrid-5-yl carbamoyl] indoline] and chlordiazepoxide produced differential effects on electroencephalogram power spectraSandor Kantor, Rita Jakus, Eszter Molnar, et al.
The International Journal of Neuropsychopharmacology|February 12, 2008
Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 daysEszter Kirilly, Eszter Molnar, Brigitta Balogh, et al.
Analytical Biochemistry|June 2, 2009
Detection of protein complex interactions via a Blue Native-PAGE retardation assayMahima Swamy, Eszter Molnar, Thomas Bock, et al.
Advances in Experimental Medicine and Biology|December 11, 2008
Segregation modelsElaine P Dopfer, Mahima Swamy, Gabrielle M Siegers, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|September 3, 2009
Promoter variants of the cannabinoid receptor 1 gene (CNR1) in interaction with 5-HTTLPR affect the anxious phenotypeJudit Lazary, Aron Lazary, Xenia Gonda, et al.
Neurochemistry International|July 12, 2011
Association between the activation of MCH and orexin immunorective neurons and REM sleep architecture during REM rebound after a three day long REM deprivationTamas Kitka, Csaba Adori, Zita Katai, et al.
Pageof 2